✦ LIBER ✦

PEG-interferon-induced allograft dysfunction in liver transplant recipients with hepatitis C recurrence: De novo autoimmune hepatitis?

✍ Scribed by Sonia Berardi; Francesca Lodato; Annagiulia Gramenzi; Antonia D’Errico; Maria Cristina Morelli; Giuseppe Mazzella; Fabio Piscaglia; Pietro Andreone; Marco Lenzi

Book ID: 119228267
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 51 KB
Volume: 38
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2006.06.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Late onset cytomegalovirus disease in li

Late onset cytomegalovirus disease in liver transplant recipients: de novo reactivation in recurrent hepatitis C virus hepatitis

✍ Nina Singh; Adriana Zeevi; Timothy Gayowski; Ignazio R. Marino 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 372 KB

Late onset cytomegalovirus disease in li

Late onset cytomegalovirus disease in liver transplant recipients: de novo reactivation in recurrent hepatitis C virus hepatitis

✍ N. Singh; Adriana Zeevi; Timothy Gayowski; Ignazio R. Marino 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 179 KB

Immune-mediated liver dysfunction after

Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis c: Allo or autoimmune de novo hepatitis?

✍ M. Merli; F. Gentili; M. Giusto; A.F. Attili; S.G. Corradini; G. Mennini; M. Ros 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 542 KB

Pegylated-interferon for recurrent hepat

Pegylated-interferon for recurrent hepatitis C in liver transplant recipients with renal failure

✍ Sandeep Mukherjee; Richard K Gilroy; Timothy M McCashland; Daniel F Schafer; Row 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 24 KB

Relapse Response to Interferon and Ribav

Relapse Response to Interferon and Ribavirin in Liver Transplant Recipient With Hepatitis C Recurrence

✍ P. Coccoli; G. Cordone; M. Bruno; G. Parrilli 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Sustained viral response to interferon a

Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C

✍ Manal F. Abdelmalek; Roberto J. Firpi; Consuelo Soldevila-Pico; Alan I. Reed; Al 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB 👁 1 views

Recurrent hepatitis C infection is an important cause of progressive fibrosis, cirrhosis, and graft loss following orthotopic liver transplantation. Treatment for posttransplant recurrence of hepatitis C with interferon-based therapy is difficult but results in loss of detectable virus in up to 30%